Open Access
- 9 February 2026
- journal article
- conference paper
- Published by MDPI AG in Société Internationale d’Urologie Journal
- Vol. 7 (1) , 2
Abstract
The 7th Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting, organized in conjunction with the 45th Annual Congress of the Société Internationale d’Urologie, was held on 31 October 2025, in Edinburgh, Scotland, and transmitted live on the SIU@U Congress appKeywords
Funding Information
- Daiichi Sankyo | AstraZeneca
- Johnson and Johnson
- Bristol Myers Squibb
- CG Oncology
- Ferring Pharmaceuticals
- Merck Sharp & Dohme
- Novartis Pharma AG
This publication has 67 references indexed in Scilit:
- What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An International Neoadjuvant Kidney Cancer Consortium Delphi studyAnnals of Oncology, 2025
- Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trialAnnals of Oncology, 2025
- Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trialInternational Journal of Cancer, 2024
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2024
- Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up dataCancer Immunology, Immunotherapy, 2024
- Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinomaCancer, 2022
- Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving SunitinibJAMA Oncology, 2019
- Survival after complete surgical resection of multiple metastases from renal cell carcinomaCancer, 2011
- A review of human cell radiosensitivity in vitroInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen renal cancer study groupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1987